Fri, Sep 19, 2014, 12:43 AM EDT - U.S. Markets open in 8 hrs 47 mins


% | $
Quotes you view appear here for quick access.

Ligand Pharmaceuticals Incorporated Message Board

  • long_vrts2 long_vrts2 Jan 22, 2013 3:18 PM Flag

    Case report: Promacta + romiplostin effective in severe thrombocytopenia

    Hematology. 2013 Jan 8. [Epub ahead of print]

    Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab.
    Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Velázquez-Sánchez-de-Cima S, Zamora-Ortiz G.

    A 58-year-old woman presented with rheumatoid arthritis-associated Evans syndrome (simultaneous autoimmune hemolytic anemia and autoimmune thrombocytopenic purpura); she was treated unsuccesfully with steroids, romiplostin, rituximab, immunoglobulin G, and splenectomy. The platelet count responded to the combined use of prednisone, eltrombopag, and romiplostin. It may be more reasonable to use combined treatments than sequential monotherapies.

    [PubMed - as supplied by publisher]

    SortNewest  |  Oldest  |  Most Replied Expand all replies
50.79-0.34(-0.66%)Sep 18 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Sep 18, 2014 4:04 PM EDT
Rite Aid Corporation
NYSEThu, Sep 18, 2014 4:02 PM EDT
The Boeing Company
NYSEThu, Sep 18, 2014 4:00 PM EDT